117928-94-6 | Rapastinel

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$156.00	$109.00
5mg	95%	in stock	$322.00	$225.00
10mg	95%	in stock	$505.00	$354.00
25mg	95%	in stock	$892.00	$624.00
50mg	95%	in stock	$1,674.00	$1,172.00
100mg	95%	in stock	$1,956.00	$1,369.00

Description

• Catalog Number: AE11548
• Chemical Name: Rapastinel
• CAS Number: 117928-94-6
• Molecular Formula: C18H31N5O6
• Molecular Weight: 413.46864000000005
• MDL Number: MFCD12912477
• SMILES: C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)O

Upstream Synthesis Route

Rapastinel, also known as GLYX-13, is a novel synthetic peptide that has shown promising results in chemical synthesis. This compound has been widely studied for its potential application as a therapeutic agent for treating depression and other neurological disorders. In chemical synthesis, Rapastinel has demonstrated unique properties that make it a valuable tool for researchers and chemists.One notable application of Rapastinel in chemical synthesis is its role as a peptide-based drug candidate. Peptides are important molecules that play a crucial role in biological processes, and they have emerged as a popular class of therapeutic agents due to their high selectivity and low toxicity. Rapastinel's structure and properties make it an attractive candidate for developing peptide-based drugs with improved efficacy and safety profiles.Furthermore, Rapastinel has been shown to exhibit neuroprotective properties, making it a potentially valuable compound for designing novel neuroprotective agents. Its mechanism of action as a partial agonist of the N-methyl-D-aspartate (NMDA) receptor suggests that it could offer new opportunities for developing drugs that target the central nervous system.Overall, Rapastinel's unique properties and potential therapeutic benefits make it a promising candidate for chemical synthesis applications, particularly in the development of novel peptide-based drugs and neuroprotective agents.